nach oben

Erschienen in:

01.03.2011 | Editorial

World Kidney Day 2011: Protect your kidneys, save your heart

verfasst von: William G. Couser, Miguel C. Riella, For the Joint International Society of Nephrology (WGC) and International Federation of Kidney Foundations (MCR) World Kidney Day 2011 Steering Committee

Erschienen in: Pediatric Nephrology | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Excerpt

March 10, 2011, will mark the celebration of the 6th World Kidney Day (WKD), an annual event jointly sponsored by the International Society of Nephrology and the International Federation of Kidney Foundations. Since its inception in 2006, WKD has grown dramatically to become the most widely celebrated event associated with kidney disease in the world and the most successful effort to raise awareness among both the general public and government health officials about the dangers of kidney disease, especially chronic kidney disease (CKD). …

World Health Organization (2005) Preventing Chronic Diseases: A Vital Investment: WHO Global Report. 2008-2013 action plan for the global strategy for the prevention and control of noncommunicable diseases: prevent and control cardiovascular diseases, cancers, chronic respiratory diseases and diabetes.

Anderson GF, Chu E (2007) Expanding priorities – Confronting chronic disease in countries with low income. N Engl J Med 356:209–211PubMedCrossRef

Narayan KM, Ali MK, Koplan JP (2010) Global noncommunicable diseases–where worlds meet. N Engl J Med 363:1196–1198PubMedCrossRef

Ritz E, Bakris G, World Kidney Day Organising Committee (2009) World Kidney Day: hypertension and chronic kidney disease. Lancet 373:1157–1158PubMedCrossRef

Atkins RC, Zimmet P, ISN-IFKF World Kidney Day Steering Committee (2010) Diabetic kidney disease: act now or pay later. Nat Rev Nephrol 6:134–136PubMedCrossRef

Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296–305PubMedCrossRef

Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX (2006) Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 17:2034–2047PubMedCrossRef

Hillege HL, Fidler V, Diercks GFH, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, Gans ROB, Janssen WMT, Grobbee DE, de Jong PE (2002) Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106:1777–1782PubMedCrossRef

Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen G, Clausen P, Scharling H, Appleyard M, Jensen JS (2004) Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 110:32–35PubMedCrossRef

10.

van Domburg RT, Hoeks SE, Welten GMJM, Chonchol M, Elhendy A, Poldermans D (2008) Renal insufficiency and mortality in patients with known or suspected coronary artery disease. J Am Soc Nephrol 19:158–163PubMedCrossRef

11.

Rashidi A, Sehgal AR, Rahman M, O'Connor AS (2008) The case for chronic kidney disease, diabetes mellitus, and myocardial infarction being equivalent risk factors for cardiovascular mortality in patients older than 65 years. Am J Cardiol 102:1668–1673PubMedCrossRef

12.

McCullough PA, Li S, Jurkovitz CT, Stevens LA, Wang C, Collins AJ, Chen SC, Norris KC, McFarlane SI, Johnson B, Shlipak MG, Obialo CI, Brown WW, Vassalotti JA, Whaley-Connell AT, Kidney Early Evaluation Program Investigators (2008) CKD and Cardiovascular Disease in Screened High-Risk Volunteer and General Populations: The Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis 51:S38–S45PubMedCrossRef

13.

McCullough PA, Jurkovitz CT, Pergola PE, McGill JB, Brown WW, Collins AJ, Chen SC, Li S, Singh A, Norris KC, Klag MJ, Bakris GL, KEEP Investigators (2007) Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP). Arch Intern Med 167:1122–1129PubMedCrossRef

14.

McCullough PA, Li S, Jurkovitz CT, Stevens L, Collins AJ, Chen SC, Norris KC, McFarlane S, Johnson B, Shlipak MG, Obialo CI, Brown WW, Vassalotti J, Whaley-Connell AT, Brenner RM, Bakris GL, Investigators KEEP (2008) Chronic kidney disease: prevalence of premature cardiovascular disease and relationship to short-term mortality. Am Heart J 156:277–283PubMedCrossRef

15.

Astor BC, Hallan SI, Miller ER 3rd, Yeung E, Coresh J (2008) Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. Am J Epidemiol 167:1226–1233PubMedCrossRef

16.

Irie F, Iso H, Sairenchi T, Fukasawa N, Yamagishi K, Ikehara S, Kanashiki M, Saito Y, Ota H, Nose T (2006) The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population. Kidney Int 69:1264–1271PubMedCrossRef

17.

Granger CB, Swedberg K, Pfeffer MA, Yusuf S, McMurray JJ, Investigators CHARM (2009) Individuals at Increased renal risk. J Am Soc Nephrol 20:852–862CrossRef

18.

Tonelli M, Jose P, Curhan G, Sacks F, Braunwald E, Pfeffer M, Cholesterol and Recurrent Events (CARE) Trial Investigators (2006) Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial. BMJ 332:1426PubMedCrossRef

19.

Matsushita K, Selvin E, Bash LD, Franceschini N, Astor BC, Coresh J (2009) Change in estimated GFR associates with coronary heart disease and mortality. J Am Soc Nephrol 20:2617–2624PubMedCrossRef

20.

Malyszko J, Bachorzewska-Gajewska H, Malyszko JS, Dobrzycki SMalyszko J, Bachorzewska-Gajewska H, Malyszko JS, Dobrzycki S (2010) Prevalence of chronic kidney disease in elderly patients with normal serum creatinine levels undergoing percutaneous coronary interventions. Gerontol 56:51–54CrossRef

21.

Hemmelgarn BR, Manns BJ, Lloyd A, James MT, Klarenbach S, Quinn RR, Wiebe N, Tonelli M, Alberta Kidney Disease Network (2010) Relation between kidney function, proteinuria, and adverse outcomes. JAMA 303:423–429PubMedCrossRef

22.

Gansevoort RT, de Jong PE (2009) The case for using albuminuria in staging chronic kidney disease. J Am Soc Nephrol 20:465–468PubMedCrossRef

23.

Chronic Kidney Disease Prognosis Consortium (2010) Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 375:2073–2081CrossRef

24.

Abdelhafiz AH, Brown SH, Bello A, El Nahas M (2010) Chronic kidney disease in older people: physiology, pathology or both? Nephron Clin Pract 116:19–24CrossRef

25.

Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345:861–869PubMedCrossRef

26.

Ruggenenti P, Perna A, Gherardi G, Garini G, Zoccali C, Salvadori M, Scolari F, Schena FP, Remuzzi G (1999) Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet 354:359–364PubMedCrossRef

27.

Ruggenenti P, Perna A, Gherardi G, Gaspari F, Benini R, Remuzzi G (1998) Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy. Lancet 352:1252–1256PubMedCrossRef

28.

The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia) (1997) Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 349:1857–1863CrossRef

29.

The ESCAPE trial group (2009) Strict blood pressure control and progression of renal failure in children. New Engl J Med 361:1639–1650CrossRef

30.

Asselbergs FW, Diercks GF, Hillege HL, van Boven AJ, Janssen WM, Voors AA, de Zeeuw D, de Jong PE, van Veldhuisen DJ, van Gilst WH (2004) Prevention of Renal and Vascular Endstage Disease Intervention Trial (PREVEND IT) Investigators. Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria. Circulation 110:2809–2816PubMedCrossRef

31.

Atthobari J, Asselbergs FW, Boersma C, de Vries R, Hillege HL, van Gilst WH, Gansevoort RT, de Jong PE, de Jong-van den Berg LT, Postma MJ, PREVEND IT Study Group (2006) Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT). Clin Ther 28:432–444PubMedCrossRef

32.

de Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, Shahinfar S, Snapinn S, Brenner BM (2004) Albuminuria: a therapeutic target for cardiovascular protection in type 2 diabetic nephropathy. Circulation 110:921–927PubMedCrossRef

33.

Eijkelkamp WB, Zhang Z, Remuzzi G, Parving HH, Cooper ME, Keane WF, Shahinfar S, Gleim GW, Weir MR, Brenner BM, de Zeeuw D (2007) Albuminuria is a target for renoprotective therapy independent from blood pressure in type II diabetic patients with nephropathy. Post hoc analysis from the Reduction in End Points in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial. J Am Soc Nephrol 18:1540–1546PubMedCrossRef

34.

Muirhead N, Rene de Cotret P, Chiu A, Pichette V, Tobe S, SMART (Supra Maximal Atacand Renal Trial) Investigators, (2009) Supramaximal dose of candesartan in proteinuric renal disease. J Am Soc Nephrol 20:893–900PubMedCrossRef

35.

Vogt L, Waanders F, Boomsma F, de Zeeuw D, Navis G (2009) Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan. J Am Soc Nephrol 19:999–1007CrossRef

36.

Fried L (2009) Are we ready to screen the general population for microalbuminuria? J Am Soc Nephrol 20:686–688PubMedCrossRef

37.

El Nahas M (2005) The global challenge of chronic kidney disease. (Nephrology Forum) Kidney Int 68:2918–2929CrossRef

38.

Barsoum RS (2006) Chronic kidney disease in the developing world. New Engl J Med 354:997–999PubMedCrossRef

39.

Levey AS, Schoolwerth AC, Burrows NR, Williams DE, Stith KR, McClellan W, Centers for Disease Control and Prevention Expert Panel (2009) Comprehensive public health strategies for preventing the development, progression, and complications of CKD: report of an expert panel convened by the Centers for Disease Control and Prevention. Am J Kidney Dis 53:522–535PubMedCrossRef

40.

James MT, Hemmelgarn BR, Tonelli M (2010) Early recognition and prevention of CKD. Lancet 379:1296–1309CrossRef

41.

Perico N, Bravo RF, De Leon FR, Remuzzi G (2009) Screening for chronic kidney disease in emerging countries: feasibility and hurdles. Nephrol Dial Transplant 24:1355–1358PubMedCrossRef

Titel: World Kidney Day 2011: Protect your kidneys, save your heart
verfasst von: William G. Couser
Miguel C. Riella
For the Joint International Society of Nephrology (WGC) and International Federation of Kidney Foundations (MCR) World Kidney Day 2011 Steering Committee
Publikationsdatum: 01.03.2011
Verlag: Springer-Verlag
Erschienen in: Pediatric Nephrology / Ausgabe 3/2011
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI: https://doi.org/10.1007/s00467-010-1754-0

Neu im Fachgebiet Pädiatrie

18.04.2024 | Spinale Muskelatrophien | Nachrichten

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

World Kidney Day 2011: Protect your kidneys, save your heart

Excerpt

Neu im Fachgebiet Pädiatrie

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

Zunahme von Geschlechtsinkongruenz und -dysphorie registriert

Stillende Frauen haben geringeres kardiovaskuläres Risiko

Update Pädiatrie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2011

Pathogenesis, diagnosis and management of hyperkalemia

Primary versus secondary hypertension in children followed up at an outpatient tertiary unit

Renal failure induced by Cortinarius poisoning

Fatal renal failure caused by Cortinarius mushrooms

Cyclosporin A therapy for Henoch–Schönlein nephritis with nephrotic-range proteinuria

Neonatal nephrotic syndrome associated with placental transmission of proinflammatory cytokines

Neu im Fachgebiet Pädiatrie

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

Zunahme von Geschlechtsinkongruenz und -dysphorie registriert

Stillende Frauen haben geringeres kardiovaskuläres Risiko

Update Pädiatrie